Employees
74
Industry
Surgical and Medical Instrument Manufacturing
advanced excimer laser-based vascular and dermatological therapies we are a commercial-stage medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases. we believe our products enhance patients’ quality of life by restoring blood-flow in arteries and clearing chronic skin conditions. we currently manufacture and market two lines of products: dabra catheter and laser is cleared by the u.s. fda as a tool for the minimally invasive endovascular treatment of vascular blockages resulting from lower extremity vascular disease, which includes peripheral artery disease (pad), which commonly occurs in the legs. pharos excimer laser pharos is designed for use in the treatment of inflammatory skin conditions and is fda cleared as a tool used in the treatment of psoriasis, atopic dermatitis, and leukoderma. our goal is to become the leading medical device company marketing excimer lasers as tools for the treatment of
Loading...
Open
0.55
Mkt cap
3.8M
Volume
75K
High
0.59
P/E Ratio
-0.02
52-wk high
11.13
Low
0.52
Div yield
N/A
52-wk low
0.48
Portfolio Pulse from Happy Mohamed
August 17, 2023 | 12:06 pm
Portfolio Pulse from Happy Mohamed
August 14, 2023 | 12:47 pm
Portfolio Pulse from Benzinga Newsdesk
August 07, 2023 | 12:08 pm
Portfolio Pulse from Benzinga Newsdesk
July 31, 2023 | 12:09 pm
Portfolio Pulse from Benzinga Insights
July 24, 2023 | 9:32 pm
Portfolio Pulse from Benzinga Insights
July 24, 2023 | 7:48 pm
Portfolio Pulse from Happy Mohamed
July 24, 2023 | 12:14 pm
Portfolio Pulse from Benzinga Insights
July 21, 2023 | 9:32 pm
Portfolio Pulse from Benzinga Insights
July 18, 2023 | 9:32 pm
Portfolio Pulse from Benzinga Insights
July 10, 2023 | 5:50 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.